$AVEO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AVEO PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AVEO PHARMACEUTICALS, INC.. Get notifications about new insider transactions in AVEO PHARMACEUTICALS, INC. for free.
Page: < prev 1 2 3 4 5 6 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 30 2013 | AVEO | AVEO PHARMACEUTICA ... | KUCHERLAPATI RAJU S | Director | Gift | G | 0.00 | 3,773 | 0 | 0 | 3.8 K to 0 (-100.00 %) |
May 30 2013 | AVEO | AVEO PHARMACEUTICA ... | KUCHERLAPATI RAJU S | Director | Gift | G | 0.00 | 42,078 | 0 | 0 | 42.1 K to 0 (-100.00 %) |
May 30 2013 | AVEO | AVEO PHARMACEUTICA ... | KUCHERLAPATI RAJU S | Director | Gift | G | 0.00 | 19,053 | 0 | 0 | 19.1 K to 0 (-100.00 %) |
Apr 24 2013 | AVEO | AVEO PHARMACEUTICA ... | EVNIN ANTHONY B | Director | Grant | A | 7.25 | 1,034 | 7,497 | 6,018 | 5 K to 6 K (+20.75 %) |
Apr 24 2013 | AVEO | AVEO PHARMACEUTICA ... | TERMEER HENRI A | Director | Grant | A | 7.25 | 2,482 | 17,995 | 102,482 | 100 K to 102.5 K (+2.48 %) |
Apr 24 2013 | AVEO | AVEO PHARMACEUTICA ... | WEG KENNETH E | Director | Grant | A | 7.25 | 1,724 | 12,499 | 43,216 | 41.5 K to 43.2 K (+4.16 %) |
Apr 24 2013 | AVEO | AVEO PHARMACEUTICA ... | YOUNG ROBERT C | Director | Grant | A | 7.25 | 844 | 6,119 | 9,844 | 9 K to 9.8 K (+9.38 %) |
Mar 14 2013 | AVEO | AVEO PHARMACEUTICA ... | Johnston David Brannon | Chief Financial Off ... | Sell | S | 7.34 | 1,061 | 7,784 | 55,943 | 57 K to 55.9 K (-1.86 %) |
Mar 11 2013 | AVEO | AVEO PHARMACEUTICA ... | TERMEER HENRI A | Director | Buy | P | 6.73 | 55,499 | 373,736 | 100,000 | 44.5 K to 100 K (+124.71 %) |
Feb 20 2013 | AVEO | AVEO PHARMACEUTICA ... | YOUNG ROBERT C | Director | Buy | P | 6.60 | 990 | 6,533 | 9,000 | 8 K to 9 K (+12.36 %) |
Jan 28 2013 | AVEO | AVEO PHARMACEUTICA ... | BAILEY MICHAEL P | Chief Commercial Of ... | Option Exercise | A | 7.72 | 32,500 | 250,900 | 32,500 | |
Jan 28 2013 | AVEO | AVEO PHARMACEUTICA ... | BAILEY MICHAEL P | Chief Commercial Of ... | Sell | S | 7.77 | 767 | 5,960 | 64,049 | 64.8 K to 64 K (-1.18 %) |
Jan 28 2013 | AVEO | AVEO PHARMACEUTICA ... | BAILEY MICHAEL P | Chief Commercial Of ... | Grant | A | 0.00 | 42,500 | 0 | 64,816 | 22.3 K to 64.8 K (+190.45 %) |
Jan 28 2013 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Operating Off ... | Option Exercise | A | 7.72 | 37,500 | 289,500 | 37,500 | |
Jan 28 2013 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Operating Off ... | Sell | S | 7.77 | 1,150 | 8,937 | 61,843 | 63 K to 61.8 K (-1.83 %) |
Jan 28 2013 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Operating Off ... | Grant | A | 0.00 | 37,500 | 0 | 62,993 | 25.5 K to 63 K (+147.10 %) |
Jan 28 2013 | AVEO | AVEO PHARMACEUTICA ... | Gyuris Jeno | SVP, Chief Scientif ... | Option Exercise | A | 7.72 | 32,500 | 250,900 | 32,500 | |
Jan 28 2013 | AVEO | AVEO PHARMACEUTICA ... | Gyuris Jeno | SVP, Chief Scientif ... | Sell | S | 7.77 | 767 | 5,960 | 111,245 | 112 K to 111.2 K (-0.68 %) |
Jan 28 2013 | AVEO | AVEO PHARMACEUTICA ... | Gyuris Jeno | SVP, Chief Scientif ... | Grant | A | 0.00 | 32,500 | 0 | 112,012 | 79.5 K to 112 K (+40.87 %) |
Jan 28 2013 | AVEO | AVEO PHARMACEUTICA ... | Johnston David Brannon | Chief Financial Off ... | Option Exercise | A | 7.72 | 32,500 | 250,900 | 32,500 | |
Jan 28 2013 | AVEO | AVEO PHARMACEUTICA ... | Johnston David Brannon | Chief Financial Off ... | Sell | S | 7.77 | 1,150 | 8,937 | 57,004 | 58.2 K to 57 K (-1.98 %) |
Jan 28 2013 | AVEO | AVEO PHARMACEUTICA ... | Johnston David Brannon | Chief Financial Off ... | Grant | A | 0.00 | 32,500 | 0 | 58,154 | 25.7 K to 58.2 K (+126.69 %) |
Jan 28 2013 | AVEO | AVEO PHARMACEUTICA ... | Jones Mary Ellen | SVP, Human Resource ... | Option Exercise | A | 7.72 | 22,500 | 173,700 | 22,500 | |
Jan 28 2013 | AVEO | AVEO PHARMACEUTICA ... | Jones Mary Ellen | SVP, Human Resource ... | Grant | A | 0.00 | 22,500 | 0 | 36,000 | 13.5 K to 36 K (+166.67 %) |
Jan 28 2013 | AVEO | AVEO PHARMACEUTICA ... | HA NGOC TUAN | Chief Executive Off ... | Option Exercise | A | 7.72 | 82,500 | 636,900 | 82,500 | |
Jan 28 2013 | AVEO | AVEO PHARMACEUTICA ... | HA NGOC TUAN | Chief Executive Off ... | Grant | A | 0.00 | 82,500 | 0 | 397,787 | 315.3 K to 397.8 K (+26.17 %) |
Jan 28 2013 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Option Exercise | A | 7.72 | 32,500 | 250,900 | 32,500 | |
Jan 28 2013 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Sell | S | 7.77 | 1,150 | 8,937 | 60,043 | 61.2 K to 60 K (-1.88 %) |
Jan 28 2013 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Grant | A | 0.00 | 37,500 | 0 | 61,193 | 23.7 K to 61.2 K (+158.27 %) |
Jan 28 2013 | AVEO | AVEO PHARMACEUTICA ... | Vittiglio Joseph | SVP & General Couns ... | Option Exercise | A | 7.72 | 22,500 | 173,700 | 22,500 | |
Jan 28 2013 | AVEO | AVEO PHARMACEUTICA ... | Vittiglio Joseph | SVP & General Couns ... | Sell | S | 7.77 | 384 | 2,984 | 29,369 | 29.8 K to 29.4 K (-1.29 %) |
Jan 28 2013 | AVEO | AVEO PHARMACEUTICA ... | Vittiglio Joseph | SVP & General Couns ... | Grant | A | 0.00 | 22,500 | 0 | 29,753 | 7.3 K to 29.8 K (+310.22 %) |
Dec 20 2012 | AVEO | AVEO PHARMACEUTICA ... | EPSTEIN ROBERT S | Director | Option Exercise | A | 7.05 | 30,000 | 211,500 | 30,000 | |
Dec 17 2012 | AVEO | AVEO PHARMACEUTICA ... | KUCHERLAPATI RAJU S | Director | Buy | P | 6.65 | 2,029 | 13,490 | 115,501 | 113.5 K to 115.5 K (+1.79 %) |
Dec 17 2012 | AVEO | AVEO PHARMACEUTICA ... | KUCHERLAPATI RAJU S | Director | Buy | P | 6.75 | 12,971 | 87,544 | 113,472 | 100.5 K to 113.5 K (+12.91 %) |
Dec 17 2012 | AVEO | AVEO PHARMACEUTICA ... | KUCHERLAPATI RAJU S | Director | Sell | J | 0.00 | 13,540 | 0 | 15,010 | 28.6 K to 15 K (-47.43 %) |
Dec 17 2012 | AVEO | AVEO PHARMACEUTICA ... | KUCHERLAPATI RAJU S | Director | Buy | J | 0.00 | 13,540 | 0 | 100,501 | 87 K to 100.5 K (+15.57 %) |
Dec 14 2012 | AVEO | AVEO PHARMACEUTICA ... | TERMEER HENRI A | Director | Buy | P | 6.65 | 5,200 | 34,562 | 44,501 | 39.3 K to 44.5 K (+13.23 %) |
Dec 14 2012 | AVEO | AVEO PHARMACEUTICA ... | TERMEER HENRI A | Director | Buy | P | 6.59 | 39,301 | 258,931 | 39,301 | 0 to 39.3 K |
Dec 14 2012 | AVEO | AVEO PHARMACEUTICA ... | YOUNG ROBERT C | Director | Buy | P | 6.78 | 171 | 1,159 | 8,010 | 7.8 K to 8 K (+2.18 %) |
Dec 14 2012 | AVEO | AVEO PHARMACEUTICA ... | YOUNG ROBERT C | Director | Buy | P | 6.78 | 2,200 | 14,905 | 7,839 | 5.6 K to 7.8 K (+39.01 %) |
Dec 14 2012 | AVEO | AVEO PHARMACEUTICA ... | HA NGOC TUAN | Chief Executive Off ... | Buy | P | 6.85 | 14,100 | 96,637 | 314,640 | 300.5 K to 314.6 K (+4.69 %) |
Dec 14 2012 | AVEO | AVEO PHARMACEUTICA ... | HA NGOC TUAN | Chief Executive Off ... | Buy | P | 6.61 | 60,900 | 402,318 | 300,540 | 239.6 K to 300.5 K (+25.41 %) |
Dec 14 2012 | AVEO | AVEO PHARMACEUTICA ... | HA NGOC TUAN | Chief Executive Off ... | Sell | J | 0.00 | 33,793 | 0 | 118,187 | 152 K to 118.2 K (-22.24 %) |
Dec 14 2012 | AVEO | AVEO PHARMACEUTICA ... | HA NGOC TUAN | Chief Executive Off ... | Buy | J | 0.00 | 33,793 | 0 | 239,640 | 205.8 K to 239.6 K (+16.42 %) |
Dec 04 2012 | AVEO | AVEO PHARMACEUTICA ... | YOUNG ROBERT C | Director | Buy | P | 6.41 | 1,250 | 8,013 | 5,639 | 4.4 K to 5.6 K (+28.48 %) |
Oct 02 2012 | AVEO | AVEO PHARMACEUTICA ... | Robinson Murray O. | SVP, Translational ... | Option Exercise | M | 2.00 | 37,500 | 75,000 | 0 | |
Oct 02 2012 | AVEO | AVEO PHARMACEUTICA ... | Robinson Murray O. | SVP, Translational ... | Buy | M | 2.00 | 37,500 | 75,000 | 141,745 | 104.2 K to 141.7 K (+35.97 %) |
Sep 14 2012 | AVEO | AVEO PHARMACEUTICA ... | Johnston David Brannon | Chief Financial Off ... | Sell | S | 10.60 | 1,386 | 14,696 | 24,593 | 26 K to 24.6 K (-5.34 %) |
Aug 09 2012 | AVEO | AVEO PHARMACEUTICA ... | YOUNG ROBERT C | Director | Buy | P | 8.63 | 1,000 | 8,630 | 4,389 | 3.4 K to 4.4 K (+29.51 %) |
Jul 18 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Option Exercise | M | 9.64 | 2,000 | 19,280 | 108,500 | |
Jul 18 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Sell | S | 13.17 | 2,000 | 26,333 | 23,693 | 25.7 K to 23.7 K (-7.78 %) |
Jul 18 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Buy | M | 9.64 | 2,000 | 19,280 | 25,693 | 23.7 K to 25.7 K (+8.44 %) |
Jul 05 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Option Exercise | M | 9.64 | 1,000 | 9,640 | 110,500 | |
Jul 05 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Sell | S | 13.00 | 1,000 | 13,000 | 23,693 | 24.7 K to 23.7 K (-4.05 %) |
Jul 05 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Buy | M | 9.64 | 1,000 | 9,640 | 24,693 | 23.7 K to 24.7 K (+4.22 %) |
Jun 12 2012 | AVEO | AVEO PHARMACEUTICA ... | EVNIN ANTHONY B | Director | Option Exercise | A | 12.78 | 12,500 | 159,750 | 12,500 | |
Jun 21 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Option Exercise | M | 9.64 | 1,000 | 9,640 | 111,500 | |
Jun 21 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Sell | S | 12.00 | 1,000 | 12,000 | 23,693 | 24.7 K to 23.7 K (-4.05 %) |
Jun 21 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Buy | M | 9.64 | 1,000 | 9,640 | 24,693 | 23.7 K to 24.7 K (+4.22 %) |
Jun 08 2012 | AVEO | AVEO PHARMACEUTICA ... | Johnston David Brannon | Chief Financial Off ... | Option Exercise | M | 5.60 | 15,000 | 84,000 | 150,000 | |
Jun 08 2012 | AVEO | AVEO PHARMACEUTICA ... | Johnston David Brannon | Chief Financial Off ... | Sell | S | 12.21 | 15,000 | 183,150 | 25,154 | 40.2 K to 25.2 K (-37.36 %) |
Jun 08 2012 | AVEO | AVEO PHARMACEUTICA ... | Johnston David Brannon | Chief Financial Off ... | Buy | M | 5.60 | 15,000 | 84,000 | 40,154 | 25.2 K to 40.2 K (+59.63 %) |
Jun 05 2012 | AVEO | AVEO PHARMACEUTICA ... | DePinho Ronald A | Director | Option Exercise | A | 12.78 | 12,500 | 159,750 | 12,500 | |
Jun 05 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Option Exercise | M | 9.64 | 1,000 | 9,640 | 112,500 | |
Jun 05 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Sell | S | 13.00 | 1,000 | 13,000 | 23,693 | 24.7 K to 23.7 K (-4.05 %) |
Jun 05 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Buy | M | 9.64 | 1,000 | 9,640 | 24,693 | 23.7 K to 24.7 K (+4.22 %) |
Jun 05 2012 | AVEO | AVEO PHARMACEUTICA ... | BATE KENNETH | Director | Option Exercise | A | 12.78 | 12,500 | 159,750 | 12,500 | |
Jun 05 2012 | AVEO | AVEO PHARMACEUTICA ... | KUCHERLAPATI RAJU S | Director | Option Exercise | A | 12.78 | 12,500 | 159,750 | 12,500 | |
Jun 05 2012 | AVEO | AVEO PHARMACEUTICA ... | TERMEER HENRI A | Director | Option Exercise | A | 12.78 | 12,500 | 159,750 | 12,500 | |
Jun 05 2012 | AVEO | AVEO PHARMACEUTICA ... | WEG KENNETH E | Director | Option Exercise | A | 12.78 | 12,500 | 159,750 | 12,500 | |
May 16 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Option Exercise | M | 9.64 | 1,000 | 9,640 | 113,500 | |
May 16 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Sell | S | 12.42 | 1,000 | 12,420 | 23,693 | 24.7 K to 23.7 K (-4.05 %) |
May 16 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Buy | M | 9.64 | 1,000 | 9,640 | 24,693 | 23.7 K to 24.7 K (+4.22 %) |
Jun 05 2012 | AVEO | AVEO PHARMACEUTICA ... | YOUNG ROBERT C | Director | Option Exercise | A | 12.78 | 12,500 | 159,750 | 12,500 | |
May 02 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Option Exercise | M | 9.64 | 1,000 | 9,640 | 114,500 | |
May 02 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Sell | S | 12.00 | 1,000 | 12,000 | 23,693 | 24.7 K to 23.7 K (-4.05 %) |
May 02 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Buy | M | 9.64 | 1,000 | 9,640 | 24,693 | 23.7 K to 24.7 K (+4.22 %) |
Apr 03 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Option Exercise | M | 9.64 | 1,000 | 9,640 | 115,500 | |
Apr 03 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Sell | S | 12.38 | 1,000 | 12,377 | 23,693 | 24.7 K to 23.7 K (-4.05 %) |
Apr 03 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Buy | M | 9.64 | 1,000 | 9,640 | 24,693 | 23.7 K to 24.7 K (+4.22 %) |
Mar 12 2012 | AVEO | AVEO PHARMACEUTICA ... | Gyuris Jeno | SVP, Chief Scientif ... | Sell | S | 13.07 | 2,000 | 26,130 | 79,512 | 81.5 K to 79.5 K (-2.45 %) |
Mar 07 2012 | AVEO | AVEO PHARMACEUTICA ... | Gyuris Jeno | SVP, Chief Scientif ... | Sell | S | 13.00 | 2,000 | 26,000 | 81,512 | 83.5 K to 81.5 K (-2.39 %) |
Mar 07 2012 | AVEO | AVEO PHARMACEUTICA ... | Gyuris Jeno | SVP, Chief Scientif ... | Sell | S | 13.17 | 3,000 | 39,501 | 83,512 | 86.5 K to 83.5 K (-3.47 %) |
Mar 02 2012 | AVEO | AVEO PHARMACEUTICA ... | Gyuris Jeno | SVP, Chief Scientif ... | Sell | S | 13.16 | 2,100 | 27,636 | 86,512 | 88.6 K to 86.5 K (-2.37 %) |
Mar 02 2012 | AVEO | AVEO PHARMACEUTICA ... | Gyuris Jeno | SVP, Chief Scientif ... | Sell | S | 13.33 | 2,000 | 26,660 | 88,612 | 90.6 K to 88.6 K (-2.21 %) |
Mar 02 2012 | AVEO | AVEO PHARMACEUTICA ... | Gyuris Jeno | SVP, Chief Scientif ... | Sell | S | 13.18 | 1,000 | 13,175 | 90,612 | 91.6 K to 90.6 K (-1.09 %) |
Feb 28 2012 | AVEO | AVEO PHARMACEUTICA ... | Gyuris Jeno | SVP, Chief Scientif ... | Sell | S | 13.08 | 1,000 | 13,080 | 91,612 | 92.6 K to 91.6 K (-1.08 %) |
Feb 28 2012 | AVEO | AVEO PHARMACEUTICA ... | Gyuris Jeno | SVP, Chief Scientif ... | Sell | S | 13.68 | 1,500 | 20,525 | 92,612 | 94.1 K to 92.6 K (-1.59 %) |
Feb 24 2012 | AVEO | AVEO PHARMACEUTICA ... | Gyuris Jeno | SVP, Chief Scientif ... | Sell | S | 13.50 | 500 | 6,750 | 94,112 | 94.6 K to 94.1 K (-0.53 %) |
Feb 22 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Option Exercise | M | 9.64 | 2,000 | 19,280 | 116,500 | |
Feb 22 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Sell | S | 13.67 | 2,000 | 27,330 | 23,693 | 25.7 K to 23.7 K (-7.78 %) |
Feb 22 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Buy | M | 9.64 | 2,000 | 19,280 | 25,693 | 23.7 K to 25.7 K (+8.44 %) |
Feb 21 2012 | AVEO | AVEO PHARMACEUTICA ... | KUCHERLAPATI RAJU S | Director | Buy | P | 13.87 | 5,000 | 69,342 | 86,961 | 82 K to 87 K (+6.10 %) |
Feb 02 2012 | AVEO | AVEO PHARMACEUTICA ... | Johnston David Brannon | Chief Financial Off ... | Option Exercise | A | 13.18 | 33,500 | 441,530 | 33,500 | |
Feb 02 2012 | AVEO | AVEO PHARMACEUTICA ... | Johnston David Brannon | Chief Financial Off ... | Grant | A | 0.00 | 19,700 | 0 | 25,154 | 5.5 K to 25.2 K (+361.20 %) |
Feb 21 2012 | AVEO | AVEO PHARMACEUTICA ... | HA NGOC TUAN | Chief Executive Off ... | Option Exercise | M | 0.48 | 50,000 | 24,000 | 0 | |
Feb 21 2012 | AVEO | AVEO PHARMACEUTICA ... | HA NGOC TUAN | Chief Executive Off ... | Buy | M | 0.48 | 50,000 | 24,000 | 204,639 | 154.6 K to 204.6 K (+32.33 %) |
Feb 02 2012 | AVEO | AVEO PHARMACEUTICA ... | Gyuris Jeno | SVP, Head of Resear ... | Option Exercise | A | 13.18 | 27,700 | 365,086 | 27,700 | |
Feb 02 2012 | AVEO | AVEO PHARMACEUTICA ... | Gyuris Jeno | SVP, Head of Resear ... | Grant | A | 0.00 | 16,300 | 0 | 94,612 | 78.3 K to 94.6 K (+20.81 %) |
Feb 02 2012 | AVEO | AVEO PHARMACEUTICA ... | BAILEY MICHAEL P | Chief Commercial Of ... | Option Exercise | A | 13.18 | 31,000 | 408,580 | 31,000 | |
Feb 02 2012 | AVEO | AVEO PHARMACEUTICA ... | BAILEY MICHAEL P | Chief Commercial Of ... | Grant | A | 0.00 | 18,200 | 0 | 22,316 | 4.1 K to 22.3 K (+442.18 %) |
Feb 02 2012 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Business Offi ... | Option Exercise | A | 13.18 | 35,100 | 462,618 | 35,100 | |
Feb 02 2012 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Business Offi ... | Grant | A | 0.00 | 20,600 | 0 | 25,493 | 4.9 K to 25.5 K (+421.01 %) |
Feb 02 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Option Exercise | A | 13.18 | 31,900 | 420,442 | 31,900 | |
Feb 02 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Grant | A | 0.00 | 18,800 | 0 | 23,693 | 4.9 K to 23.7 K (+384.22 %) |
Feb 02 2012 | AVEO | AVEO PHARMACEUTICA ... | HA NGOC TUAN | President & CEO | Option Exercise | A | 13.18 | 93,500 | 1,232,330 | 93,500 | |
Feb 02 2012 | AVEO | AVEO PHARMACEUTICA ... | HA NGOC TUAN | President & CEO | Grant | A | 0.00 | 55,000 | 0 | 154,639 | 99.6 K to 154.6 K (+55.20 %) |
Jan 30 2012 | AVEO | AVEO PHARMACEUTICA ... | HA NGOC TUAN | President & CEO | Sell | S | 13.37 | 4,613 | 61,656 | 99,639 | 104.3 K to 99.6 K (-4.42 %) |
Jan 30 2012 | AVEO | AVEO PHARMACEUTICA ... | HA NGOC TUAN | President & CEO | Sell | J | 0.00 | 18,349 | 0 | 151,980 | 170.3 K to 152 K (-10.77 %) |
Jan 30 2012 | AVEO | AVEO PHARMACEUTICA ... | HA NGOC TUAN | President & CEO | Buy | J | 0.00 | 18,349 | 0 | 103,741 | 85.4 K to 103.7 K (+21.49 %) |
Jan 30 2012 | AVEO | AVEO PHARMACEUTICA ... | Johnston David Brannon | Chief Financial Off ... | Sell | S | 13.37 | 1,107 | 14,796 | 5,454 | 6.6 K to 5.5 K (-16.87 %) |
Jan 30 2012 | AVEO | AVEO PHARMACEUTICA ... | BAILEY MICHAEL P | Chief Commercial Of ... | Sell | S | 13.37 | 738 | 9,864 | 4,116 | 4.9 K to 4.1 K (-15.20 %) |
Jan 30 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Sell | S | 13.37 | 1,107 | 14,796 | 4,893 | 6 K to 4.9 K (-18.45 %) |
Jan 30 2012 | AVEO | AVEO PHARMACEUTICA ... | Gyuris Jeno | SVP, Head of Resear ... | Sell | S | 13.37 | 738 | 9,864 | 78,312 | 79.1 K to 78.3 K (-0.93 %) |
Jan 30 2012 | AVEO | AVEO PHARMACEUTICA ... | Ezickson Elan | Chief Business Offi ... | Sell | S | 13.37 | 1,107 | 14,796 | 4,893 | 6 K to 4.9 K (-18.45 %) |
Jan 19 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Option Exercise | M | 9.64 | 2,000 | 19,280 | 118,500 | |
Jan 19 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Sell | S | 14.87 | 2,000 | 29,736 | 6,000 | 8 K to 6 K (-25.00 %) |
Jan 19 2012 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Buy | M | 9.64 | 2,000 | 19,280 | 8,000 | 6 K to 8 K (+33.33 %) |
Dec 23 2011 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Option Exercise | M | 9.64 | 2,000 | 19,280 | 120,500 | |
Dec 23 2011 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Sell | S | 17.00 | 2,000 | 34,000 | 6,000 | 8 K to 6 K (-25.00 %) |
Dec 23 2011 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Buy | M | 9.64 | 2,000 | 19,280 | 8,000 | 6 K to 8 K (+33.33 %) |
Dec 21 2011 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Option Exercise | M | 9.64 | 3,000 | 28,920 | 122,500 | |
Dec 21 2011 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Sell | S | 15.79 | 3,000 | 47,369 | 6,000 | 9 K to 6 K (-33.33 %) |
Dec 21 2011 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Buy | M | 9.64 | 3,000 | 28,920 | 9,000 | 6 K to 9 K (+50.00 %) |
Dec 05 2011 | AVEO | AVEO PHARMACEUTICA ... | Johnston David Brannon | Chief Financial Off ... | Option Exercise | M | 5.60 | 1,000 | 5,600 | 165,000 | |
Dec 05 2011 | AVEO | AVEO PHARMACEUTICA ... | Johnston David Brannon | Chief Financial Off ... | Sell | S | 16.74 | 1,000 | 16,737 | 6,000 | 7 K to 6 K (-14.29 %) |
Dec 05 2011 | AVEO | AVEO PHARMACEUTICA ... | Johnston David Brannon | Chief Financial Off ... | Buy | M | 5.60 | 1,000 | 5,600 | 7,000 | 6 K to 7 K (+16.67 %) |
Dec 05 2011 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Option Exercise | M | 9.64 | 2,000 | 19,280 | 125,500 | |
Dec 05 2011 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Sell | S | 17.00 | 2,000 | 34,000 | 6,000 | 8 K to 6 K (-25.00 %) |
Dec 05 2011 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Buy | M | 9.64 | 2,000 | 19,280 | 8,000 | 6 K to 8 K (+33.33 %) |
Nov 16 2011 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Option Exercise | M | 9.64 | 3,000 | 28,920 | 127,500 | |
Nov 16 2011 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Sell | S | 15.72 | 3,000 | 47,161 | 6,000 | 9 K to 6 K (-33.33 %) |
Nov 16 2011 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Buy | M | 9.64 | 3,000 | 28,920 | 9,000 | 6 K to 9 K (+50.00 %) |
Nov 02 2011 | AVEO | AVEO PHARMACEUTICA ... | Johnston David Brannon | Chief Financial Off ... | Option Exercise | M | 5.60 | 2,000 | 11,200 | 166,000 | |
Nov 02 2011 | AVEO | AVEO PHARMACEUTICA ... | Johnston David Brannon | Chief Financial Off ... | Sell | S | 15.44 | 2,000 | 30,878 | 6,000 | 8 K to 6 K (-25.00 %) |
Nov 02 2011 | AVEO | AVEO PHARMACEUTICA ... | Johnston David Brannon | Chief Financial Off ... | Buy | M | 5.60 | 2,000 | 11,200 | 8,000 | 6 K to 8 K (+33.33 %) |
Oct 31 2011 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Option Exercise | M | 9.64 | 2,000 | 19,280 | 130,500 | |
Oct 31 2011 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Sell | S | 17.00 | 2,000 | 34,000 | 6,000 | 8 K to 6 K (-25.00 %) |
Oct 31 2011 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Buy | M | 9.64 | 2,000 | 19,280 | 8,000 | 6 K to 8 K (+33.33 %) |
Oct 20 2011 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Option Exercise | M | 9.64 | 3,000 | 28,920 | 132,500 | |
Oct 20 2011 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Sell | S | 15.91 | 3,000 | 47,727 | 6,000 | 9 K to 6 K (-33.33 %) |
Oct 20 2011 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Buy | M | 9.64 | 3,000 | 28,920 | 9,000 | 6 K to 9 K (+50.00 %) |
Oct 04 2011 | AVEO | AVEO PHARMACEUTICA ... | Johnston David Brannon | Chief Financial Off ... | Option Exercise | M | 5.60 | 2,000 | 11,200 | 168,000 | |
Oct 04 2011 | AVEO | AVEO PHARMACEUTICA ... | Johnston David Brannon | Chief Financial Off ... | Sell | S | 15.43 | 2,000 | 30,867 | 6,000 | 8 K to 6 K (-25.00 %) |
Oct 04 2011 | AVEO | AVEO PHARMACEUTICA ... | Johnston David Brannon | Chief Financial Off ... | Buy | M | 5.60 | 2,000 | 11,200 | 8,000 | 6 K to 8 K (+33.33 %) |
Sep 21 2011 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Option Exercise | M | 9.64 | 5,000 | 48,200 | 135,500 | |
Sep 21 2011 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Sell | S | 16.72 | 5,000 | 83,608 | 6,000 | 11 K to 6 K (-45.45 %) |
Sep 21 2011 | AVEO | AVEO PHARMACEUTICA ... | Slichenmyer William | Chief Medical Offic ... | Buy | M | 9.64 | 5,000 | 48,200 | 11,000 | 6 K to 11 K (+83.33 %) |
Sep 07 2011 | AVEO | AVEO PHARMACEUTICA ... | Johnston David Brannon | Chief Financial Off ... | Option Exercise | M | 5.60 | 2,000 | 11,200 | 170,000 |